Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis

Conditions

• Candidemia
• Mycoses
• Fungal Infection
• Invasive Candidiases

Interventions

• DRUG: Rezafungin for Injection
• DRUG: Caspofungin
• DRUG: Fluconazole
• DRUG: intravenous placebo
• DRUG: oral placebo

Sponsor

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)